Drugmakers call for pro-R&D policies

Published: 2013-05-28 07:00:00

Updated: 2013-05-28 07:00:00

The domestic pharmaceutical industry may become one of the new growth engines for the Korean economy, but it there are still many challenges to overcome, such as a lack of incentives to attract domestic and foreign pharmaceutical firms’ investment, according to industry experts.

Experts claime...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK